PLU-1/Jarid1B contributes to estrogen-induced cell proliferation in the normal mammary gland and in breast cancer, and is required for embryonic survival

被引:0
|
作者
Catchpole, S. [1 ]
Spencer-Dene, B. [2 ]
Hall, D. [1 ]
Scibetta, A. [1 ]
Burchell, J. [1 ]
Taylor-Papadimitriou, J. [1 ]
机构
[1] Kings Coll London, London, England
[2] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England
关键词
Breast Cancer; Mammary Gland; Normal Mammary Gland; Mammary Phenotype; Embryonic Survival;
D O I
10.1186/bcr2514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S6 / S7
页数:2
相关论文
共 42 条
  • [31] Bisphenol A-Induced Cell Proliferation and Mitochondrial Oxidative Stress Are Diminished via Modulation of TRPV1 Channel in Estrogen Positive Breast Cancer Cell by Selenium Treatment
    Kadriye Görkem Ulu Güzel
    Mustafa Nazıroğlu
    Derya Ceyhan
    Biological Trace Element Research, 2020, 198 : 118 - 130
  • [32] Bisphenol A-Induced Cell Proliferation and Mitochondrial Oxidative Stress Are Diminished via Modulation of TRPV1 Channel in Estrogen Positive Breast Cancer Cell by Selenium Treatment
    Guzel, Kadriye Gorkem Ulu
    Naziroglu, Mustafa
    Ceyhan, Derya
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 198 (01) : 118 - 130
  • [33] Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells
    Abdelrahim, M
    Samudio, I
    Smith, R
    Burghardt, R
    Safe, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) : 28815 - 28822
  • [35] FOXP1, an Estrogen-Inducible Transcription Factor, Modulates Cell Proliferation in Breast Cancer Cells and 5-Year Recurrence-Free Survival of Patients with Tamoxifen-Treated Breast Cancer
    Shigekawa T.
    Ijichi N.
    Ikeda K.
    Horie-Inoue K.
    Shimizu C.
    Saji S.
    Aogi K.
    Tsuda H.
    Osaki A.
    Saeki T.
    Inoue S.
    Hormones and Cancer, 2011, 2 (5): : 286 - 297
  • [36] An Estrogen-Inducible Transcription Factor FOXP1 Promotes Estrogen-Dependent Cell Proliferation of Breast Cancer Cells and Is Associated with 5-Year Disease-Free Survival in Patients with Tamoxifen-Treated Breast Cancer.
    Shigekawa, T.
    Ijichi, N.
    Ikeda, K.
    Horie-Inoue, K.
    Shimizu, C.
    Saji, S.
    Aogi, K.
    Tsuda, H.
    Osaki, A.
    Saeki, T.
    Inoue, S.
    CANCER RESEARCH, 2011, 71
  • [37] Respective contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor α induced transcriptional activity by isoflavones and equol: Consequence on breast cancer cell proliferation
    Carreau, Charlotte
    Flouriot, Gilles
    Bennetau-Pelissero, Catherine
    Potier, Mylene
    MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 (05) : 652 - 658
  • [38] SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
    Zhang, Lei
    Yuan, Chenwei
    Peng, Jing
    Zhou, Liheng
    Jiang, Yiwei
    Lin, Yanping
    Yin, Wenjin
    Xu, Shuguang
    Ma, Jun
    Lu, Jinsong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] Organic anion transporting polypeptide 2B1 expression correlates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells
    Matsumoto, Jun
    Ariyoshi, Noritaka
    Sakakibara, Masahiro
    Nakanishi, Takeo
    Okubo, Yoshiyuki
    Shiina, Nobumitsu
    Fujisaki, Kaoru
    Nagashima, Takeshi
    Nakatani, Yukio
    Tamai, Ikumi
    Yamada, Harumi
    Takeda, Hiroshi
    Ishii, Itsuko
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (02) : 133 - 141
  • [40] Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro
    Simard, J
    Labrie, C
    Belanger, A
    Gauthier, S
    Singh, SM
    Merand, Y
    Labrie, F
    INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (01) : 104 - 112